Your browser doesn't support javascript.
loading
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.
Zhang, Peijing; Xiao, Zhenna; Wang, Shouyu; Zhang, Mutian; Wei, Yongkun; Hang, Qinglei; Kim, Jongchan; Yao, Fan; Rodriguez-Aguayo, Cristian; Ton, Baochau N; Lee, Minjung; Wang, Yumeng; Zhou, Zhicheng; Zeng, Liyong; Hu, Xiaoyu; Lawhon, Sarah E; Siverly, Ashley N; Su, Xiaohua; Li, Jia; Xie, Xiaoping; Cheng, Xuhong; Liu, Liang-Chiu; Chang, Hui-Wen; Chiang, Shu-Fen; Lopez-Berestein, Gabriel; Sood, Anil K; Chen, Junjie; You, M James; Sun, Shao-Cong; Liang, Han; Huang, Yun; Yang, Xianbin; Sun, Deqiang; Sun, Yutong; Hung, Mien-Chie; Ma, Li.
Afiliação
  • Zhang P; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei 430074, C
  • Xiao Z; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Science, Houston, TX 77030, USA.
  • Wang S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhang M; Center for Epigenetics & Disease Prevention, Texas A&M University Institute of Biosciences & Technology, Houston, TX 77030, USA.
  • Wei Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Hang Q; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kim J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Yao F; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Rodriguez-Aguayo C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ton BN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lee M; Center for Epigenetics & Disease Prevention, Texas A&M University Institute of Biosciences & Technology, Houston, TX 77030, USA; Department of Molecular & Cellular Medicine, College of Medicine, Texas A&M University, College Station, TX 77843, USA.
  • Wang Y; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhou Z; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zeng L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Hu X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lawhon SE; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Siverly AN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Su X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Li J; Center for Epigenetics & Disease Prevention, Texas A&M University Institute of Biosciences & Technology, Houston, TX 77030, USA.
  • Xie X; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Cheng X; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Liu LC; Division of Breast Surgery, Department of Surgery, China Medical University Hospital, Taichung 404, Taiwan.
  • Chang HW; Department of Pathology, China Medical University Hospital, Taichung 404, Taiwan.
  • Chiang SF; Cancer Center, China Medical University Hospital, Taichung 404, Taiwan.
  • Lopez-Berestein G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Chen J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • You MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sun SC; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Liang H; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texa
  • Huang Y; Center for Epigenetics & Disease Prevention, Texas A&M University Institute of Biosciences & Technology, Houston, TX 77030, USA; Department of Molecular & Cellular Medicine, College of Medicine, Texas A&M University, College Station, TX 77843, USA.
  • Yang X; AM Biotechnologies, Houston, TX 77034, USA.
  • Sun D; Center for Epigenetics & Disease Prevention, Texas A&M University Institute of Biosciences & Technology, Houston, TX 77030, USA.
  • Sun Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Hung MC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung 404, Taiwan.
  • Ma L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Science, Houston, TX 77030, USA. Electronic address: lma4@mdanderson.org.
Cell Rep ; 23(3): 823-837, 2018 Apr 17.
Article em En | MEDLINE | ID: mdl-29669287
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Proteases Específicas de Ubiquitina Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Proteases Específicas de Ubiquitina Idioma: En Ano de publicação: 2018 Tipo de documento: Article